Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DANISH HEALTHCARE DESIGN A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.9% 2.9%   Bankruptcy risk   0.7% 0.7% 0.8% 0.7% 0.6% 0.7% 9.1% 8.9%   Credit score (0-100)   96 94 90 94 96 95 27 28   Credit rating   AA AA A AA AA AA BB BB   Credit limit (kDKK)   1,256.8 1,053.0 716.8 1,164.5 1,349.3 1,233.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   22,675 21,006 17,794 19,450 20,825 19,600 0.0 0.0   EBITDA   3,128 3,826 2,141 7,246 8,261 6,211 0.0 0.0   EBIT   1,916 2,179 551 5,314 7,235 5,412 0.0 0.0   Pre-tax profit (PTP)   1,459.1 1,678.8 302.4 5,157.4 7,054.2 5,013.0 0.0 0.0   Net earnings   1,131.0 1,363.3 229.6 4,020.2 5,499.4 3,892.2 0.0 0.0   Pre-tax profit without non-rec. items   1,459 1,293 302 5,157 7,054 5,013 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   16,575 17,229 16,179 15,005 14,378 16,023 0.0 0.0   Shareholders equity total   6,017 6,380 4,609 6,230 6,929 6,821 5,121 5,121   Interest-bearing liabilities   17,566 15,772 9,719 6,600 9,432 11,422 0.0 0.0   Balance sheet total (assets)   32,898 31,782 25,266 24,367 23,822 26,475 5,121 5,121   Net Debt   13,679 15,640 8,745 6,437 9,429 11,420 -5,121 -5,121     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   22,675 21,006 17,794 19,450 20,825 19,600 0.0 0.0   Gross profit growth   -4.1% -7.4% -15.3% 9.3% 7.1% -5.9% -100.0% 0.0%   Employees   41 35 33 25 25 27 0 0   Employee growth %   -2.4% -14.6% -5.7% -24.2% 0.0% 8.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   32,898 31,782 25,266 24,367 23,822 26,475 5,121 5,121   Balance sheet change%   -11.2% -3.4% -20.5% -3.6% -2.2% 11.1% -80.7% 0.0%   Added value   3,128.2 3,826.3 2,140.9 7,245.7 9,167.3 6,211.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   8,989 -5,754 -3,380 -3,765 -1,652 845 -16,023 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.5% 10.4% 3.1% 27.3% 34.7% 27.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.7% 7.0% 2.3% 21.7% 30.4% 21.9% 0.0% 0.0%   ROI %   6.9% 8.3% 2.8% 30.3% 40.4% 26.2% 0.0% 0.0%   ROE %   15.7% 22.0% 4.2% 74.2% 83.6% 56.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   18.7% 20.1% 18.8% 25.7% 29.1% 25.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   437.3% 408.8% 408.5% 88.8% 114.1% 183.9% 0.0% 0.0%   Gearing %   292.0% 247.2% 210.8% 105.9% 136.1% 167.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 5.9% 2.7% 2.9% 3.4% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.7 0.5 0.3 0.3 0.3 0.0 0.0   Current Ratio   1.0 1.2 1.1 0.7 0.7 0.7 0.0 0.0   Cash and cash equivalent   3,887.0 131.7 974.1 162.6 3.0 2.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   302.8 2,280.5 968.0 -4,556.4 -4,574.5 -4,757.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   76 109 65 290 367 230 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   76 109 65 290 330 230 0 0   EBIT / employee   47 62 17 213 289 200 0 0   Net earnings / employee   28 39 7 161 220 144 0 0